Qube Research & Technologies LTD Ionis Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $11.8 Million - $14.8 Million	319,027 Added 2727.43%	330,724 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $427,408 - $569,176	11,697 New	11,697 $517,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $5.96 Million - $7.93 Million	-131,618 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $6.25 Million - $8.29 Million	131,618 New	131,618 $6.25 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $525,891 - $685,286	-11,225 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $229,132 - $349,207	5,508 Added 96.34%	11,225 $531,000
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $307,860 - $373,148	5,717 New	5,717 $345,000

401

146M

916K

552K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.6B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.